AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06703710 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JW2286
Description: a single administration of JW2286 per dose
Study NCT06703710 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of JW2286
Description: a single administration of Placebo of JW2286 per dose
Study NCT06703437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dehydrated alcohol
Description: Long-acting neuraxial blockade at the time of prostate biopsy by periprostatic injection of Dehydrated alcohol.
Study NCT06703437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine IV
Description: By periprostatic injection, 2mL
Study NCT04822246 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intervention 2: Hand excavation + EMS Airflow device for caries excavation
Description: The participants allocated to this group will have the caries excavated as described for the control group. Then prior to filling the excavated cavity, the procedure of sodium bicarbonate powder-water jet irrigation as described for the intervention group #1 will be performed to condition the prepared excavated cavity. Then the restorative procedure will be completed with the restorative material and procedures as described for the previous groups.
Study NCT05788536 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: DB-OTO
Description: DB-OTO will be administered as a single intracochlear injection into one ear (Part A).~* LD Cohort (starting dose)~* HD Cohort (high dose)
Study NCT05788536 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: DB-OTO
Description: DB-OTO will be administered as a single intracochlear injection into both ears (Part B). For bilateral injections (Part B), patients will receive DB-OTO in 1 surgical session.
Study NCT04994418 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Recommended sodium and low fructose diet
Description: Upon completion of a 7 day dietary intervention of consuming the daily recommended sodium and low fructose contents we will investigate changes in ambulatory blood pressure, urinary sodium excretion, heart rate variability, secretion of inflammatory cytokines, and reactive oxygen species.
Study NCT04994418 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High sodium and low fructose diet
Description: Upon completion of a 7 day dietary intervention of consuming the daily high sodium and low fructose contents we will investigate changes in ambulatory blood pressure, urinary sodium excretion, heart rate variability, secretion of inflammatory cytokines, and reactive oxygen species.
Study NCT04994418 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High sodium and high fructose diet
Description: Upon completion of a 7 day dietary intervention of consuming the high sodium and high fructose contents we will investigate changes in ambulatory blood pressure, urinary sodium excretion, heart rate variability, secretion of inflammatory cytokines, and reactive oxygen species.
Study NCT06703294 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Crow's feet injection filling
Description: Patients with crow's feet of different degree were randomly divided into two groups, which were injected with bovine collagen and humanized collagen respectively
Study NCT06703294 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Humanized collagen filling crow's feet
Description: Bovine collagen filling crow's feet
Study NCT06703775 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Description: The first experimental will receive LLLT using the Fisioline Lumix 2 (Italy). Participants will be placed in a comfortable, supported sitting position and will wear protective eyeglasses to prevent retinal damage. The LLLT (GaAs type, 1-10 mW, 904 nm) will be applied to the most painful points on the deltoid and/or upper trapezius muscles. Treatment will target a minimum of two and a maximum of four painful points, with each point irradiated for 3-4 minutes, for a total session duration of up to 15 minutes.
Study NCT06703775 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neural mobilization techniques
Description: The second experimental will receive Neural Mobilization Therapy (NMT). The procedure will begin by positioning the patient in a sitting position. The initial positioning will involve placing the patient's arm at their side with the elbow bent at 90 degrees. The therapist will gently extend the patient's shoulder (moving the arm backward) while keeping the elbow bent, creating tension on the axillary nerve. This tension will be held for a few seconds, ensuring it remains within the patient's tolerance and does not cause discomfort or pain. The shoulder will then be slowly returned to the initial position, releasing the tension on the nerve. This sequence of tension and release will be repeated, gradually increasing the range of motion as tolerated. The treatment will consist of three sets of 10 repetitions, with a one-minute rest between sets, performed three times per week for a total of 12 sessions over four weeks.
Study NCT06703775 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy program
Description: The following exercises will be performed by the patients of three groups. Pendulum exercise, Isometric Scapular Retraction, Rotator cuff exercise, Wall creeping exercise, Active assisted ROM exercises, Codman exercises. Each exercise will be performed for all movements namely flexion extension and abduction-adduction, one sets of each 10-15 repetitions within pain-free range and instructed to carry out their activities of daily living.
Study NCT06703775 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy program
Description: The following exercises will be performed by the patients of three groups. Pendulum exercise, Isometric Scapular Retraction, Rotator cuff exercise, Wall creeping exercise, Active assisted ROM exercises, Codman exercises. Each exercise will be performed for all movements namely flexion extension and abduction-adduction, one sets of each 10-15 repetitions within pain-free range and instructed to carry out their activities of daily living.
Study NCT06360549 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Acupoint Stimulation
Description: Transcutaneous Electrical Acupoint Stimulation (TEAS) is a treatment that combines acupoint theory of traditional Chinese medicine with modern electrical stimulation techniques. It achieves the purpose of acupoint stimulation by applying a weak current to a specific part. TEAS operate just like ordinary electrodes with non-invasive, safe, portable, adjustable and other advantages.
Study NCT06702696 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Black chokeberry (Aronia melanocarpa)
Description: The aronia group, who will consume 30 g of freeze-dried aronia powder (n=25)
Study NCT06702696 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo powder
Description: The placebo group, who will consume placebo powder (n=25).
Study NCT05318118 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Medial Meniscus Arthroscopic Reconstruction Using the Fast Fix
Description: Arthroscopic reconstruction of damaged Medial Meniscus using Fast-Fix (Smith \& Nephew) implant.
Study NCT05318118 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Medial Meniscus Arthroscopic Reconstruction Using the Fiber Stitch
Description: Arthroscopic reconstruction of damaged Medial Meniscus using Fiber-Stitch (Arthrex) implant
Study NCT06333444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: four weekly psychological counselling intervention
Description: four weekly psychological counselling intervention delivered by university students asking help to university counselling service in Southern Italy
Study NCT06302764 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Qualitative & Quantitative Research
Description: 1. Focused interviews - conducted by members of the appointed research team to recognize the issues faced by emergency medical staff in Poland, Ukraine, Portugal, and Spain with the aim of preparing the measurement framework.~2. Online questionnaire surveys - conducted using the Qualtrics platform (available in different, language versions - Polish, Ukrainian, Portuguese, and Spanish).
Study NCT05525429 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition Education
Description: Multidimensional nutrition education will be provided.
Study NCT05458895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECIG lab session 1
Description: vaping session with e-liquid including a standardized, 5-minute, 10-puff vaping bout (30 seconds between each puff) followed by 30 minutes of ad libitum (as desired) vaping.
Study NCT05458895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECIG lab session 2
Description: vaping session with e-liquid including a standardized, 5-minute, 10-puff vaping bout (30 seconds between each puff) followed by 30 minutes of ad libitum (as desired) vaping.
Study NCT04530175 — intervention group
Intervention type: OTHER
Intervention: blood sampling
Description: 2 blood samples will be taken from the blood circuit 1 hour after the start of the hemodialysis session by the nurse in charge of the patient.
Study NCT05458895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECIG lab session 3
Description: vaping session with e-liquid including a standardized, 5-minute, 10-puff vaping bout (30 seconds between each puff) followed by 30 minutes of ad libitum (as desired) vaping.
Study NCT05458895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECIG lab session 4
Description: vaping session with e-liquid including a standardized, 5-minute, 10-puff vaping bout (30 seconds between each puff) followed by 30 minutes of ad libitum (as desired) vaping.
Study NCT05458895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECIG lab session 5
Description: vaping session with e-liquid including a standardized, 5-minute, 10-puff vaping bout (30 seconds between each puff) followed by 30 minutes of ad libitum (as desired) vaping.
Study NCT05458895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECIG lab session 6
Description: vaping session with e-liquid including a standardized, 5-minute, 10-puff vaping bout (30 seconds between each puff) followed by 30 minutes of ad libitum (as desired) vaping.
Study NCT05458895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECIG lab session 7
Description: vaping session with e-liquid including a standardized, 5-minute, 10-puff vaping bout (30 seconds between each puff) followed by 30 minutes of ad libitum (as desired) vaping.
Study NCT05458895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECIG lab session 8
Description: vaping session with e-liquid including a standardized, 5-minute, 10-puff vaping bout (30 seconds between each puff) followed by 30 minutes of ad libitum (as desired) vaping.
Study NCT06313294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tracking application app
Description: An app will be implemented for mobile monitoring in patients who use continuous postoperative ambulatory regional analgesia.
Study NCT06313294 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Telephone interview
Description: Patients who use continuous postoperative outpatient regional analgesia will be followed up using the current traditional method of post-discharge telephone call.
Study NCT06520358 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute Intermittent Hypoxia (AIH)
Description: Acute intermittent hypoxia refers to brief (acute), repetitive (intermittent) episodes of breathing oxygen-deprived air (hypoxia) alternating with breathing ambient room air.
Study NCT06520358 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Task specific Airway Protection Training
Description: The vLVC maneuver involves training participants to volitionally prolong closure of the laryngeal vestibule during swallowing, beginning with swallow onset and sustaining closure for at least 2 seconds.
Study NCT06520358 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Task specific Airway Protection Training
Description: The vLVC maneuver involves training participants to volitionally prolong closure of the laryngeal vestibule during swallowing, beginning with swallow onset and sustaining closure for at least 2 seconds.
Study NCT06520358 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham AIH
Description: Sham AIH will be delivered using methods identical to AIH, except a normoxic gas mixture (\~21% O2) will be delivered. The gas mixture with normoxic air will effectively serve as a sham.
Study NCT06229262 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Mango group
Description: Participants will consume 1.5 cups of mangos per day for 12 weeks.
Study NCT05674487 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trans-cervical balloon
Description: Induction of labor by cervical ripening with trans-cervical balloon (Foley catheter).
Study NCT05674487 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Misoprostol
Description: Induction of labor by cervical ripening with Prostaglandins (Misoprostol per os)
Study NCT04652635 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nail plate removal, nail bed repair
Description: Injection of local anesthetic, removal of nail plate, inspection of nail bed, repair of nail bed with suture and/or adhesive
Study NCT05863351 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05863351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05863351 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05863351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05863351 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05863351 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05863351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Radiotherapy
Description: Undergo SAbR
Study NCT05863351 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Systemic Therapy
Description: Given standard of care systemic therapy
Study NCT05863351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Systemic Therapy
Description: Given standard of care systemic therapy
Study NCT04821076 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet intervention - caloric restriction
Description: Energy restriction is set to 25 kcal / kg fat-free mass
Study NCT06449573 — intervention group
Intervention type: OTHER
Intervention: Exercise capacity
Description: cardiopulmonary exercise test used assessment of exercise capacity
Study NCT06574347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vebreltinib
Description: Subjects will receive Vebreltinib orally twice per day (BID).
Study NCT06574347 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Osimertinib
Description: Subjects will receive Osimertinib 80mg orally once per day (QD).
Study NCT06574347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PLB1004
Description: Subjects will receive PLB1004 80mg orally once per day (QD).
Study NCT05314153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brexanolone
Description: Brexanolone injection is an Federal Drug Administration (FDA)-approved drug to treat postpartum depression. It is administered via continuous intravenous infusion over a 60-hour time period.
Study NCT06327126 — intervention group
Intervention type: PROCEDURE
Intervention: two-session ERCP
Description: early endoscopic drainage followed by endoscopic stone extraction
Study NCT06327126 — intervention group
Intervention type: PROCEDURE
Intervention: single-session ERCP
Description: directly endoscopic stone extraction
Study NCT01164748 — intervention group
Intervention type: RADIATION
Intervention: Lymphoscintigraphy
Description: in all women a lymphoscintigraphy was done to investigate drainage patterns of a previous operated breast and axilla
Study NCT06531707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen + Loratadine fixed dose
Description: Suspension 8,000 mg / 100 mg / 100 mL, 5 mL twice a day
Study NCT06531707 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: Suspension 2,000 mg / 100 mL, 20 mL twice a day
Study NCT06531707 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Loratadine
Description: Suspension 1 mg / 1 mL, 5 mL twice a day
Study NCT06531460 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish oil enteral supplementation
Description: Omega-3 (4.2 g), administered through an enteral feeding tube, three days before surgery
Study NCT06531460 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish oil oral supplementation
Description: Omega-3 (4.2 g), orally administered enriched nutritional formula, drinking at home three days before surgery
Study NCT06531460 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Enteral nutrition without fish oil
Description: Enteral formula without omega-3 administered through an enteral feeding tube, three days before surgery
Study NCT06531460 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Oral nutritional supplement without fish oil
Description: Oral nutritional supplement without omega-3 orally administered, drinking at home three days before surgery
Study NCT04839497 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees
Description: Autologous Volar Fibroblasts Treatment- harvested from patient's biopsied volar skin. Intradermal injection of Volar fibroblasts in the residual limb of transtibial amputees.
Study NCT06534294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: reflexology
Description: Reflex therapy was done for each patient for 30 minutes, first for the right foot and then for the left foot (15 minutes each) and breathing exercises in 3 stages
Study NCT06534294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: breathing exercise
Description: breathing exercise done as 3 stages,stage one for 5 minutes, stage two for 10 minutes end stage ; Close eyes and focus your present feelings, Then Relax the whole body for 5 minutes.
Study NCT06534294 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: standard care
Description: standard medical care no other treatment
Study NCT05382364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tucatinib
Description: Tucatinib 150 mg and 50 mg tablets taken by mouth at a dose of 300 mg twice daily.
Study NCT05762107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subject receives Placebo by subcutaneous injection daily for 28 days
Study NCT05103683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TORL-1-23
Description: antibody drug conjugate (ADC)
Study NCT05762107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZT-01, 7 mg
Description: Subject receives ZT-01 7 mg by subcutaneous injection daily for 28 days
Study NCT05762107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZT-01, 15 mg
Description: Subject receives ZT-01 15 mg by subcutaneous injection daily for 28 days
Study NCT05762107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZT-01, 22 mg
Description: Subject receives ZT-01 22 mg by subcutaneous injection daily for 28 days
Study NCT06655935 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ordinary Transcatheter ASD closure
Description: deploying the Amplatzer delivery system of the Amplatzer™ Septal Occluders ASO inside the left atrial cavity over stiff wire into the pulmonary veins
Study NCT06655935 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: modified transcatheter ASD closure
Description: deploying the Amplatzer delivery system of the Amplatzer™ Septal Occluders ASO over the multipurpose catheter inside the left atrial cavity which might help in the shortage of the duration \& the cost of the procedure with less complication rate
Study NCT06654310 — intervention group
Intervention type: BEHAVIORAL
Intervention: Delivery of FCS Skills Curriculum
Description: The UW study team will conduct two 2-hour train-the-trainer sessions with all surgical attendings who have committed to participation as a trainer in the FCS curriculum. The designated trainer will deliver each 2-hour session during the existing formal educational time for residents. If existing protected educational time will not allow for a 2-hour training session, the sessions can be delivered in two 1-hour sessions. These sessions will be incorporated into the curriculum similar to all other formal training provided to residents with the same expectations to attend.~Each 2-hour FCS session starts with a 30-minute exercise in empathic communication. The remaining 90 minutes are devoted to skills that support decision making about surgery.
Study NCT06573216 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wrist Ambulatory Blood Pressure Monitor
Description: Comparing blood pressure measured by wrist blood pressure monitor with mercury sphygmomanometer .
Study NCT06662721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 MG
Description: The patients received Baricitinib for 48 weeks. The method is to take Baricitinib 4mg every day for a period of 48 weeks. All the patients will be followed up prospectively for 48 weeks.